Effect of fasting status on Alzheimer's disease blood biomarkers
This data suggests that for some AD BBMs, there may be statistically significant differences in concentrations of samples collected in fasting versus non-fasting conditions. However, further studies are needed to determine if the observed differences may affect the clinical interpretation of these BBMs in individuals with amyloid related pathology.
Authors
- Alicia Algeciras‐Schimnich (ORCID: https://orcid.org/0000-0002-4455-6217)
- Joshua A. Bornhorst (ORCID: https://orcid.org/0009-0003-9297-3271)
- Daniel J. Figdore (ORCID: https://orcid.org/0000-0002-4776-3203)
- Bethany J. Schuder
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102762
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00